Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Amryt Pharma plc

Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
High Court of Justice of England and Wales Sanctions Scheme of Arrangement
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
AMRYT PUBLISHES SCHEME CIRCULAR AND ANNOUNCES THE SHAREHOLDER MEETINGS TO CONSIDER AND VOTE ON THE CHIESI ACQUISITION WILL BE HELD ON MARCH 22, 2023
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
COMP Adopts Positive Opinion on Orphan Designation for Mycapssa® for the Treatment of Carcinoid Syndrome Associated with Neuroendocrine Tumors
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
European Commission approves Mycapssa® for the treatment of Acromegaly
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Announces New Patent for Mycapssa®
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Reports Q3 2022 Financial and Operational Results
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Supports Acromegaly Awareness Day 2022
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
The British Journal of Dermatology Publishes Results from Amryt’s EASE Phase 3 Trial in Epidermolysis Bullosa
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Supports Global EB Awareness Week 2022
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt to Report Q3 2022 Results on November 3, 2022
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
COMP adopts positive opinion on Orphan Disease Designation for Mycapssa® for the treatment of Acromegaly
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)
From Amryt Pharma plc
Via GlobeNewswire
Tickers AMYT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.